China controls partly to blame for graft incident By: MarketWatch July 25, 2013 at 23:52 PM EDT Official intervention in the health care sector distorts pricing, and any cleanup of the system that ignores this will be futile, Caixin Online reports. Read More >> Related Stocks: Gsk Plc ADR
